Stock detail
Janux Therapeutics (JANX) stock price, chart, and key data
View Janux Therapeutics stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Janux Therapeutics
JANX · XNAS
-$1.00 (-6.45%) past month
$14.50
After hours $14.84 (+2.32%)
Key metrics
Close price
$14.50
52-week range
$12.12 - $35.34
Market cap
$878.8M
About the company
Janux Therapeutics Inc
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app